Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inverness acquisition

This article was originally published in The Tan Sheet

Executive Summary

Inverness Medical Innovations announces Feb. 5 it has acquired substantially all the assets of First Check Diagnostics for approximately $25 mil. in cash. First Check is the "market leader" of home testing for drugs of abuse, including marijuana, cocaine, methamphetamines and opiates, according to the press release. Waltham, Mass.-based Inverness will pay "an earn out to First Check equal to the incremental growth of the acquired products for 2007 and for the first nine months of 2008." Recently, Inverness entered into a joint venture with Procter & Gamble to develop, market and sell existing and future consumer diagnostic products (1"The Tan Sheet" Jan. 1, 2007, p. 10)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100207

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel